11.07.2015 Views

User Guide to Thresholds and Classification - Environmental ...

User Guide to Thresholds and Classification - Environmental ...

User Guide to Thresholds and Classification - Environmental ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

237<strong>User</strong> <strong>Guide</strong> for <strong>Thresholds</strong> <strong>and</strong> <strong>Classification</strong>sA substance for which data from one- or two-generation studies indicate evidence of any adverseeffect in the offspring of animals due <strong>to</strong> any adverse effect on the quality of milk as a result ofexposure.The classification criteria are based on the Globally Harmonised System of <strong>Classification</strong> <strong>and</strong> Labelling(GHS) (United Nations, 2007) criteria. See Appendix 16B for a comparison for the HSNO Act criteria with theGHS <strong>and</strong> Appendix 16C for comparisons with EU risk phrases for reproductive <strong>and</strong> developmental <strong>to</strong>xicity.The placing of a substance in category 6.8A for effects on fertility <strong>and</strong>/or developmental <strong>to</strong>xicity is done onthe basis of epidemiological data. Placement in<strong>to</strong> category 6.8A or 6.8B is done primarily on the basis ofanimal data. Data from in vitro studies or studies on avian eggs are regarded as ‗supportive evidence‘ <strong>and</strong>would only exceptionally lead <strong>to</strong> classification in the absence of in vivo data.For classification in<strong>to</strong> category 6.8A, for developmental <strong>to</strong>xicity, there should be clear evidence of adverseeffects in well-conducted studies in one or more species. Since adverse effects in pregnancy or postnatallymay result as a secondary consequence of events such as:maternal <strong>to</strong>xicity;reduced food or water intake;maternal stress;lack of maternal care;specific dietary deficiencies;poor animal husb<strong>and</strong>ry; <strong>and</strong>intercurrent infections.It is important that the effects observed should occur in well-conducted studies <strong>and</strong> at dose levels that arenot associated with marked maternal <strong>to</strong>xicity.The route of exposure is also important. In particular, the injection of irritant material intraperi<strong>to</strong>neally mayresult in local damage <strong>to</strong> the uterus <strong>and</strong> its contents. The results of such studies should be interpreted withcaution, <strong>and</strong> on their own would not normally lead <strong>to</strong> classification.Classify as category 6.8A, (known human reproductive or developmental <strong>to</strong>xicant) if evidence from hum<strong>and</strong>ata shows a causal relationship between exposure <strong>to</strong> the substance <strong>and</strong> the development of reproductive<strong>and</strong>/or developmental effects <strong>and</strong> in which chance, bias, <strong>and</strong> confounding could be ruled out with reasonableconfidence.Classify as category 6.8A (presumed human reproductive or developmental <strong>to</strong>xicant), if one of the followingis the case.Evidence from animal data establishes a causal relationship between the substance <strong>and</strong> thedevelopment of reproductive <strong>and</strong>/or developmental effects. Data should provide clear evidence ofspecific reproductive <strong>to</strong>xicity in the absence of <strong>to</strong>xic effects or, if occurring <strong>to</strong>gether with other <strong>to</strong>xiceffects, the adverse effect is considered not <strong>to</strong> be a secondary non-specific consequence of other <strong>to</strong>xiceffects. Mechanistic information should also support the relevance of the effect in humans.January 2012 EPA0109

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!